Rolf Kaiser

10.1k citations

287 papers · 5.9k indexed · h-index 43

Impact in

Virology top 0.2%
- HIV Research and Treatment
Infectious Diseases top 0.5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in ⓘ

Virology 135
- HIV Research and Treatment 133
Infectious Diseases 167
- HIV/AIDS drug development and treatment 132
- HIV/AIDS Research and Interventions 80
- Parvovirus B19 Infection Studies 9

Co-authors: Thomas Lengauer (72 shared papers)Saleta Sierra (26 shared papers)Martin Däumer (40 shared papers)Niko Beerenwinkel (22 shared papers)Daniel Hoffmann (22 shared papers)Alexander Thielen (18 shared papers)Joachim Selbig (16 shared papers)Jürgen Brockmöller (10 shared papers)
Journals: Journal of Clinical Virology (20 papers)Medical Microbiology and Immunology (13 papers)PLoS ONE (12 papers)Journal of Medical Virology (9 papers)Antiviral Therapy (8 papers)
Partner nations: Germany Italy United States

In The Last Decade

Rolf Kaiser

264 papers receiving 5.7k citations

Peers

Countries citing papers authored by Rolf Kaiser

Since Specialization

Citations

This map shows the geographic impact of Rolf Kaiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Kaiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Kaiser more than expected).

Fields of papers citing papers by Rolf Kaiser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf Kaiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Kaiser. The network helps show where Rolf Kaiser may publish in the future.

Co-authors

The 25 scholars most cited alongside Rolf Kaiser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rolf Kaiser Line = papers co-authored together Rolf Kaiser links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 287 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Bioinformatics prediction of HIV coreceptor usage Nature Biotechnology ·Thomas Lengauer, Oliver Sander, Saleta Sierra, Alexander Thielen, Rolf Kaiser	2007	244
2	Diversity and complexity of HIV-1 drug resistance: A bioinformatics approach to predicting phenotype from genotype Proceedings of the National Academy of Sciences ·Niko Beerenwinkel, Bárbara Schmidt, Hauke Walter, Rolf Kaiser, Thomas Lengauer, Daniel Hoffmann, Klaus Korn, Joachim Selbig	2002	183
3	CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine Journal of Clinical Pharmacy and Therapeutics ·Mohamed E. E. Shams, Borros Arneth, Christoph Hiemke, Anđela Dragićević, Michael J. Müller, Rolf Kaiser, Karl J. Lackner, Sebastian Härtter	2006	178
4	Predicting HIV Coreceptor Usage on the Basis of Genetic and Clinical Covariates Antiviral Therapy ·Tobias Sing, Andrew Low, Niko Beerenwinkel, Oliver Sander, Peter K. Cheung, Francisco S. Domingues, Joachim Büch, Martin Däumer, Rolf Kaiser, Thomas Lengauer, P. Richard Harrigan	2007	135
5	T– and B–Cell Responses to Different Hepatitis C Virus Antigens in Patients With Chronic Hepatitis C Infection and in Healthy Anti– Hepatitis C Virus—Positive Blood Donors Without Viremi Hepatology ·Martin Lechmann, Hans Georg Ihlenfeldt, I Braunschweiger, G. Giers, G. Jung, B. Matz, Rolf Kaiser, Tilman Sauerbruch, Ulrich Spengler	1996	127
6	Antiretroviral Therapy Optimisation without Genotype Resistance Testing: A Perspective on Treatment History Based Models PLoS ONE ·Mattia Prosperi, Michal Rosen‐Zvi, André Altmann, Maurizio Zazzi, Simona Di Giambenedetto, Rolf Kaiser, Eugen Schülter, Daniel Struck, P.M.A. Sloot, David van de Vijver, Anne–Mieke Vandamme, Anders Sönnerborg, (unknown)	2010	108
7	l-Dopa-induced adverse effects in PD and dopamine transporter gene polymorphism Neurology ·Rolf Kaiser, A. Höfer, A. Grapengiesser, Thomas Gasser, Andreas Kupsch, Ivar Roots, Jürgen Brockmöller	2003	104
8	CD30 induction and cytokine profiles in hepatitis C virus core-specific peripheral blood T lymphocytes The Journal of Immunology ·Rainer P. Woitas, Martin Lechmann, G. Jung, Rolf Kaiser, Tilman Sauerbruch, Ulrich Spengler	1997	103
9	Basics of the virology of HIV-1 and its replication Journal of Clinical Virology ·Saleta Sierra, Bernd Kupfer, Rolf Kaiser	2005	90
10	On the triggering of the Ultimate Regime of convection New Journal of Physics ·P.-E. Roche, F. Gauthier, Rolf Kaiser, Julien Salort	2010	89
11	Learning Multiple Evolutionary Pathways from Cross-Sectional Data Journal of Computational Biology ·Niko Beerenwinkel, Jörg Rahnenführer, Martin Däumer, Daniel Hoffmann, Rolf Kaiser, Joachim Selbig, Thomas Lengauer	2005	88
12	Primary HIV Drug Resistance and Efficacy of First-Line Antiretroviral Therapy Guided by Resistance Testing JAIDS Journal of Acquired Immune Deficiency Syndromes ·Mark Oette, Rolf Kaiser, Martin Däumer, Ruth Petch, Gerd Fätkenheuer, Horst Carls, Jürgen K. Rockstroh, Dirk Schmalöer, Jürgen Stechel, Torsten Feldt, Herbert Pfister, Dieter Häussinger	2006	81
13	Geno2pheno[HCV] – A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral Agents PLoS ONE ·Prabhav Kalaghatgi, Anna Maria Sikorski, Elena Knops, Daniel Rupp, Saleta Sierra, Eva Heger, Maria Neumann‐Fraune, Bastian Beggel, Andreas Walker, Jörg Timm, Hauke Walter, Martin Obermeier, Rolf Kaiser, Ralf Bartenschlager, Thomas Lengauer	2016	80
14	Correlation between serotonin uptake in human blood platelets with the 44‐bp polymorphism and the 17‐bp variable number of tandem repeat of the serotonin transporter American Journal of Medical Genetics ·Rolf Kaiser, B. Müller‐Oerlinghausen, Diana Filler, Pierre‐Benoit Tremblay, Anne Berghöfer, Ivar Roots, Jürgen Brockmöller	2002	77
15	Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replication Antimicrobial Agents and Chemotherapy ·J P Kleim, R. Bender, Reinhard Kirsch, C Meichsner, Arno Paessens, Manfred Rösner, Helga Rübsamen‐Waigmann, Rolf Kaiser, M. Wichers, K. E. Schneweis	1995	77
16	Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia Molecular Psychiatry ·Rolf Kaiser, P-B Tremblay, J. Schmider, Maren Henneken, Michael Dettling, B. Müller‐Oerlinghausen, Ralf Uebelhack, Ivar Roots, Jürgen Brockmöller	2001	73
17	Acute Epididymitis Revisited: Impact of Molecular Diagnostics on Etiology and Contemporary Guideline Recommendations European Urology ·Adrian Pilatz, Hamid Hossain, Rolf Kaiser, Annette Mankertz, Christian G. Schüttler, Eugen Domann, Hans‐Christian Schuppe, Trinad Chakraborty, W. Weidner, Florian Wagenlehner	2014	73
18	Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient Journal of Clinical Virology ·Sabine Awerkiew, Martin Däumer, Marcel Reiser, Ulrike C. Wend, Herbert Pfister, Rolf Kaiser, Wulf R. Willems, Wolfram H. Gerlich	2006	71
19	Computational methods for the design of effective therapies against drug resistant HIV strains Computer applications in the biosciences ·Niko Beerenwinkel, Tobias Sing, Thomas Lengauer, Jörg Rahnenführer, Kirsten Roomp, I. Savenkov, R. Fischer, Daniel Hoffmann, Joachim Selbig, Klaus Korn, Henrik Walter, Thomas Berg, Patrick Braun, Gerd Fätkenheuer, Mark Oette, Jürgen K. Rockstroh, Bernd Kupfer, Rolf Kaiser, Martin Däumer	2005	70
20	Relationship between adverse effects of antipsychotic treatment and dopamine D2 receptor polymorphisms in patients with schizophrenia Molecular Psychiatry ·Rolf Kaiser, P-B Tremblay, F Klufmöller, I Roots, Jürgen Brockmöller	2002	69

About Rolf Kaiser

Rolf Kaiser is a scholar working on Virology, Infectious Diseases, Hepatology, Epidemiology and Animal Science and Zoology, having authored 287 papers that have together received 5.9k indexed citations. Recurring topics across this work include HIV Research and Treatment (133 papers), HIV/AIDS drug development and treatment (132 papers), HIV/AIDS Research and Interventions (80 papers), Hepatitis C virus research (44 papers), Hepatitis B Virus Studies (24 papers), Animal Virus Infections Studies (12 papers), Herpesvirus Infections and Treatments (10 papers) and Parvovirus B19 Infection Studies (9 papers). The work is most often cited by research in Virology (2.4k citations), Infectious Diseases (2.6k citations), Hepatology (920 citations), Epidemiology (1.3k citations) and Pharmacology (191 citations). Rolf Kaiser has collaborated with scholars based in Germany, Italy and United States. Frequent co-authors include Thomas Lengauer, Saleta Sierra, Martin Däumer, Niko Beerenwinkel, Daniel Hoffmann, Alexander Thielen, Joachim Selbig, Jürgen Brockmöller, Ivar Roots and Herbert Pfister. Their work appears in journals such as Journal of Clinical Virology, Medical Microbiology and Immunology, PLoS ONE, Journal of Medical Virology and Antiviral Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact